1. |
Thornhill MH, Jones S, Prendergast B, et al. Quantifying infective endocarditis risk in patients with predisposing cardiac conditions. Eur Heart J, 2018, 39(7): 586-595.
|
2. |
陈星伟, 刘亚欣, 于欢, 等. 阜外医院感染性心内膜炎300例临床特征分析. 中国循环杂志, 2018, 33(11): 1102-1107.
|
3. |
Oliver L, Lavoute C, Giorgi R, et al. Infective endocarditis in octogenarians. Heart, 2017, 103(20): 1602-1609.
|
4. |
Cahill TJ, Baddour LM, Habib G, et al. Challenges in infective endocarditis. J Am Coll Cardiol, 2017, 69(3): 325-344.
|
5. |
Iung B, Rouzet F, Brochet E, et al. Cardiac imaging of infective endocarditis, echo and beyond. Curr Infect Dis Rep, 2017, 19(2): 8.
|
6. |
Huang JS, Ho AS, Ahmed A, et al. Borne identity: CT imaging of vascular infections. Emerg Radiol, 2011, 18(4): 335-343.
|
7. |
中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 成人感染性心内膜炎预防、诊断和治疗专家共识. 中华心血管病杂志, 2014, 42(10): 806-816.
|
8. |
Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J, 2015, 36(44): 3075-3128.
|
9. |
Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American Heart Association. Circulation, 2015, 132(15): 1435-1486.
|
10. |
Iversen K, Ihlemann N, Gill SU, et al. Partial oral versus intravenous antibiotic treatment of endocarditis. N Engl J Med, 2019, 380(5): 415-424.
|
11. |
Anantha Narayanan M, Mahfood Haddad T, Kalil AC, et al. Early versus late surgical intervention or medical management for infective endocarditis: A systematic review and meta-analysis. Heart, 2016, 102(12): 950-957.
|
12. |
Kang DH, Lee S, Kim YJ, et al. Long-term results of early surgery versus conventional treatment for infective endocarditis trial. Korean Circ J, 2016, 46(6): 846-850.
|
13. |
Kim YK, Choi CG, Jung J, et al. Effect of cerebral embolus size on the timing of cardiac surgery for infective endocarditis in patients with neurological complications. Eur J Clin Microbiol Infect Dis, 2018, 37(3): 545-553.
|
14. |
Murai R, Funakoshi S, Kaji S, et al. Outcomes of early surgery for infective endocarditis with moderate cerebral complications. J Thorac Cardiovasc Surg, 2017, 153(4): 831-840.
|
15. |
Tam DY, Yanagawa B, Verma S, et al. Early vs late surgery for patients with endocarditis and neurological injury: A systematic review and meta-analysis. Can J Cardiol, 2018, 34(9): 1185-1199.
|
16. |
Laperche C, Lairez O, Ferrieres J, et al. Coronary angiography in the setting of acute infective endocarditis requiring surgical treatment. Arch Cardiovasc Dis, 2020, 113(1): 50-58.
|
17. |
El-Dalati S, Shea M, Fukuhara S, et al. The role of coronary catheterization with angiography in surgically managed infectious endocarditis. Am J Med, 2020, 133(9): 1101-1104.
|
18. |
Kumar A, Anstey C, Tesar P, et al. Risk factors for mortality in patients undergoing cardiothoracic surgery for infective endocarditis. Ann Thorac Surg, 2019, 108(4): 1101-1106.
|
19. |
Varela Barca L, Navas Elorza E, Fernández-Hidalgo N, et al. Prognostic factors of mortality after surgery in infective endocarditis: Systematic review and meta-analysis. Infection, 2019, 47(6): 879-895.
|
20. |
Tao E, Wan L, Wang W, et al. The prognosis of infective endocarditis treated with biological valves versus mechanical valves: A meta-analysis. PLoS One, 2017, 12(4): e0174519.
|
21. |
Delahaye F, Chu VH, Altclas J, et al. One-year outcome following biological or mechanical valve replacement for infective endocarditis. Int J Cardiol, 2015, 178: 117-123.
|
22. |
Toyoda N, Itagaki S, Tannous H, et al. Bioprosthetic versus mechanical valve replacement for infective endocarditis: Focus on recurrence rates. Ann Thorac Surg, 2018, 106(1): 99-106.
|
23. |
Bashir M, Harky A, Froghi S, et al. A systematic review and meta-analysis of mechanical vs biological composite aortic root replacement, early and 1-year results. Gen Thorac Cardiovasc Surg, 2019, 67(1): 70-76.
|
24. |
Folkmann S, Seeburger J, Garbade J, et al. Minimally invasive mitral valve surgery for mitral valve infective endocarditis. Thorac Cardiovasc Surg, 2018, 66(7): 525-529.
|
25. |
Fleißner F, Salman J, Naqizadah J, et al. Minimally invasive surgery in mitral valve endocarditis. Thorac Cardiovasc Surg, 2019, 67(8): 637-643.
|
26. |
Hosseini S, Rezaei Y, Mazaheri T, et al. Tricuspid valve repair for infective endocarditis with periannular involvement: Complete valve reconstruction. J Heart Valve Dis, 2016, 25(6): 730-738.
|
27. |
Protos AN, Trivedi JR, Whited WM, et al. Valvectomy versus replacement for the surgical treatment of tricuspid endocarditis. Ann Thorac Surg, 2018, 106(3): 664-669.
|
28. |
Slaughter MS, Badhwar V, Ising M, et al. Optimum surgical treatment for tricuspid valve infective endocarditis: An analysis of the Society of Thoracic Surgeons national database. J Thorac Cardiovasc Surg, 2021, 161(4): 1227-1235.
|
29. |
Jiang X, Liu J, Khan F, et al. Aortic and mitral valve surgery for infective endocarditis with reconstruction of the intervalvular fibrous body: An analysis of clinical outcomes. J Thorac Dis, 2020, 12(4): 1427-1436.
|
30. |
Khan A, Aslam A, Satti KN, et al. Infective endocarditis post-transcatheter aortic valve implantation (TAVI), microbiological profile and clinical outcomes: A systematic review. PLoS One, 2020, 15(1): e0225077.
|
31. |
Bjursten H, Rasmussen M, Nozohoor S, et al. Infective endocarditis after transcatheter aortic valve implantation: A nationwide study. Eur Heart J, 2019, 40(39): 3263-3269.
|
32. |
Regueiro A, Linke A, Latib A, et al. Association between transcatheter aortic valve replacement and subsequent infective endocarditis and in-hospital death. JAMA, 2016, 316(10): 1083-1092.
|
33. |
Patel S, Rizvi SSA, Choi JH, et al. Management and outcomes of left ventricular assist device-associated endocarditis: A systematic review. Ann Cardiothorac Surg, 2019, 8(6): 600-609.
|
34. |
Flynn CD, Curran NP, Chan S, et al. Systematic review and meta-analysis of surgical outcomes comparing mechanical valve replacement and bioprosthetic valve replacement in infective endocarditis. Ann Cardiothorac Surg, 2019, 8(6): 587-599.
|
35. |
Østergaard L, Valeur N, Ihlemann N, et al. Incidence and factors associated with infective endocarditis in patients undergoing left-sided heart valve replacement. Eur Heart J, 2018, 39(28): 2668-2675.
|
36. |
Mihos CG, Capoulade R, Yucel E, et al. Surgical versus medical therapy for prosthetic valve endocarditis: A meta-analysis of 32 studies. Ann Thorac Surg, 2017, 103(3): 991-1004.
|
37. |
Lalani T, Chu VH, Park LP, et al. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Intern Med, 2013, 173(16): 1495-1504.
|